Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Valneva SE changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 450.7K | 653.5K | +202.7K (+45.0%) |
| Value | $3.60M | $4.73M | +$1.13M (+31.5%) |
New holders (2)
Institutions that held Valneva SE at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ridgewood Investments LLC | 550 | $3.86K | 0.00% |
| Activest Wealth Management | 1 | $7 | 0.00% |
Sold out (2)
Institutions that held Valneva SE at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| UBS Group AG | 962 | $7.62K |
| Federation des caisses Desjardins du Quebec | 200 | $1.58K |